Unraveling the Enigma: A Five-Year Comprehensive Analysis of Hurthle Cell Tumors in South India's Tertiary Care Center.

Autor:	Sulaiman S; General Surgery, Government Medical College Thrissur, Thrissur, IND., Chirukandath R; General Surgery, Government Medical College Thrissur, Thrissur, IND., Krishnan SK; Surgical Oncology, Government Medical College Thrissur, Thrissur, IND., Rajesh N; Surgery, Government Medical College Thrissur, Thrissur, IND., Antony M; General Surgery, Government Medical College Thrissur, Thrissur, IND., Mohan K; General Surgery, Government Medical College Thrissur, Thrissur, IND., S S; General Surgery, Government Medical College Thrissur, Thrissur, IND.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Mar 29; Vol. 16 (3), pp. e57166. Date of Electronic Publication: 2024 Mar 29 (Print Publication: 2024).
DOI:	10.7759/cureus.57166
Abstrakt:	Background: Hurthle cell tumors of the thyroid gland constitute a rare and enigmatic group of neoplasms, characterized by the presence of Hurthle cells exhibiting abundant eosinophilic cytoplasm and numerous mitochondria. Despite their low incidence, they pose diagnostic challenges and display diverse clinical outcomes. This study aims to provide a comprehensive analysis of the clinicopathological profile of Hurthle cell tumors within a tertiary care center in South India. Methods: Through a retrospective approach, we analyzed cases of Hurthle cell tumors diagnosed and treated at a tertiary care center over a five-year period. Clinical, radiological, and histopathological data were meticulously collected and scrutinized. The study focused on examining demographic details, presenting symptoms, imaging features, cytological findings, surgical management, and postoperative outcomes of the patients. Results: A total of 32 cases of Hurthle cell tumors were identified during the study period. The majority of patients were female (84%), with a mean age of 49.6 years for Hurthle cell carcinoma. Thyroid enlargement and neck mass were the most common presenting complaints. Fine-needle aspiration cytology showed characteristic features suggestive of Hurthle cell tumors in 33% of cases. Total thyroidectomy remains the mainstay surgical approach. Histopathological evaluation confirmed 62.5% of cases as benign adenomas and 37.5% as malignant carcinomas. Among malignant cases, 67% showed capsular invasion and 33% demonstrated vascular invasion. Of the patients, 33.3% received adjuvant radiotherapy. The overall survival rate was 100%. In our study, we found that thyroid nodules larger than 3 cm demonstrated a higher propensity for Hurthle cell carcinoma. Conclusion: Our findings support the multidisciplinary approach in managing Hurthle cell tumors, with a focus on tailored treatment plans for each patient based on individual characteristics. By recognizing the female predominance, assessing nodule size, and employing a combination of thyroidectomy and ablative therapy, clinicians can optimize patient care and contribute to better long-term prognosis and quality of life for those affected by Hurthle cell tumors. Continued research and collaborative efforts are necessary to advance our understanding and refine treatment strategies, paving the way for improved outcomes and enhanced patient management in the future. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Sulaiman et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu